Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Breast Cancer treatment details. Chemotherapy. University Hospital of Helsinki, Helsinki, Finland

Survival: 8.0 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Adrucil
Country: Finland
City/State/Province: Helsinki
Hospital: University Hospital of Helsinki
Journal: Link
Date: 5/2003

Patients: This Phase II trial involved a total of 60 patients with metastatic breast cancer. Patients were divided into three groups (Groups 1-3). Group 1 had 26 patients, group 2 had 24 patients, and group 3 had 10 patients.

Treatment: Each of the three groups received the same three chemotherapy drugs vinorelbine (navelbine) methotrexate and fluorouracil (5-FU, adrucil). However, the groups received them in different doses and schedules.

Toxicity: The toxicity for patients in group 3 included grade 1-4 hematological toxicities, infection, nausea, and neurotoxicity. Other toxicities (less than grade 4) included: alopecia, constipation, pain, diarrhea, local irritation, neurotoxicity, and stomatitis.

Results: Median survival time was 8 months for patients in group 3.

Correspondence: Prof. I. Elomaa

E-mail to a Friend Email Physician More Information